Prediction of drug absorption: different modeling approaches from discovery to clinical development.
نویسنده
چکیده
Drug absorption modeling is a task that requires different tools depending on the drug development stage. Scientific progress and increased computer power have initiated a veritable revolution of modeling and simulation. Technical developments have enabled a high model complexity that was unthinkable only a couple of years ago. Today, model simulations can be used to guide experimental planning and, in some cases, the extent of work can even be reduced. There are several success stories of pharmaceutical modeling and the prediction of a drug’s absorption, distribution, metabolism, and excretion (ADME) properties has certainly been of particular interest. Considering the advances in this area, the question can be raised, how close is the pharmaceutical industry to a ‘prediction paradise’ [1]. How wide are the gaps with respect to good predictions? The present editorial addresses this question, but with an exclusive focus on drug absorption modeling. The opportunities and limitations of drug absorption prediction are often viewed differently depending on the scientist asked. A discovery researcher, for example, tries to anticipate the extent of absorption based on the chemical structure alone. Approaches range from basic molecular property rules [2] to more recent approaches using advanced statistical procedures [3–7]. However, even more challenging than intestinal absorption is the prediction of oral bioavailability. In the latter case, additional drug clearance may lead to an increased scattering to the experimental data. Starting with the chemical structure, there are interesting approaches to quantitative structure–bioavailability relationship [8,9]. However, it is fair to raise the question of whether bioavailability can be well predicted at all, based on the chemical structure [10,11]. The answer to this question must, in any case, consider the various needs of prediction accuracy. In discovery, the goal is to select a promising drug candidate, thus the prediction of an absorption and bioavailability potential seems to be sufficient. However, once a drug candidate is chosen, more accurate and versatile tools are required.
منابع مشابه
Proteomics Applications in Health: Biomarker and Drug Discovery and Food Industry
Advancing in genome sequencing has greatly propelled the understanding of the living world, however, it is insufficient for full description of a biological system. Focusing on, proteomics has emerged as another large-scale platform for improving the understanding of biology. Proteomic experiments can be used for different aspects of clinical and health sciences such as food technology, biomark...
متن کاملProteomics Applications in Health: Biomarker and Drug Discovery and Food Industry
Advancing in genome sequencing has greatly propelled the understanding of the living world, however, it is insufficient for full description of a biological system. Focusing on, proteomics has emerged as another large-scale platform for improving the understanding of biology. Proteomic experiments can be used for different aspects of clinical and health sciences such as food technology, biomark...
متن کاملP115: A Novel High Tech Approach to Monitor the Pharmacotherapy of Alzheimer; a Narrative Review
Alzheimer's disease (AD) is multisystem and multifactor disease with a long no-symptom stage. We propose that a more effective approach to use fMRI as a still emerging, repeatable, non- invasive neuroimaging tools that can be very useful for evaluating, diagnosis, treatment and drugs- development. We studied 30 articles which published between 2008-2017 that included the effects of different bi...
متن کاملHuman Cancer Modeling: Recapitulating Tumor Heterogeneity Towards Personalized Medicine
Despite diagnostic, preventive and therapeutic advances, growing incidence of cancer and high rate of mortality among patients affected by specific cancer types indicate current clinical measures are not ideally useful in eradicating cancer. Chemoresistance and subsequent disease relapse are believed to be mainly driven by the cell-molecular heterogeneity of human tumors that necessitates perso...
متن کاملHuman Cancer Modeling: Recapitulating Tumor Heterogeneity Towards Personalized Medicine
Despite diagnostic, preventive and therapeutic advances, growing incidence of cancer and high rate of mortality among patients affected by specific cancer types indicate current clinical measures are not ideally useful in eradicating cancer. Chemoresistance and subsequent disease relapse are believed to be mainly driven by the cell-molecular heterogeneity of human tumors that necessitates perso...
متن کاملذخیره در منابع من
با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید
برای دانلود متن کامل این مقاله و بیش از 32 میلیون مقاله دیگر ابتدا ثبت نام کنید
ثبت ناماگر عضو سایت هستید لطفا وارد حساب کاربری خود شوید
ورودعنوان ژورنال:
- Expert review of clinical pharmacology
دوره 2 3 شماره
صفحات -
تاریخ انتشار 2009